BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35703127)

  • 1. Cyclin-dependent kinases as potential targets for colorectal cancer: past, present and future.
    M Manohar S
    Future Med Chem; 2022 Jul; 14(14):1087-1105. PubMed ID: 35703127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising Anticancer Activity of Multitarget Cyclin Dependent Kinase Inhibitors against Human Colorectal Carcinoma Cells.
    Manohar SM; Joshi KS
    Curr Mol Pharmacol; 2022; 15(7):1024-1033. PubMed ID: 35068399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer.
    Balakrishnan A; Vyas A; Deshpande K; Vyas D
    World J Gastroenterol; 2016 Feb; 22(7):2159-64. PubMed ID: 26900281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple levels of cyclin specificity in cell-cycle control.
    Bloom J; Cross FR
    Nat Rev Mol Cell Biol; 2007 Feb; 8(2):149-60. PubMed ID: 17245415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer.
    Javed A; Yarmohammadi M; Korkmaz KS; Rubio-Tomás T
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
    Zabihi M; Lotfi R; Yousefi AM; Bashash D
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell cycle and parathyroid tumor].
    Matsushime H
    Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.
    Ding L; Cao J; Lin W; Chen H; Xiong X; Ao H; Yu M; Lin J; Cui Q
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
    Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C
    EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into cyclins, CDKs, and cell cycle control.
    Sánchez I; Dynlacht BD
    Semin Cell Dev Biol; 2005 Jun; 16(3):311-21. PubMed ID: 15840440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?
    Moore JD
    Nat Rev Cancer; 2013 Mar; 13(3):201-8. PubMed ID: 23388618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coming of Age: Targeting Cyclin K in Cancers.
    Xiao Y; Dong J
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM; Sicinski P
    Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).
    Graña X; Reddy EP
    Oncogene; 1995 Jul; 11(2):211-9. PubMed ID: 7624138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.